| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $434.2M | -35.1% | +4.2% |
| Gross Profit | $370.3M | -30.1% | +5.4% |
| R&D Expense | $67.5M | -3.1% | -3.7% |
| SG&A Expense | $86.9M | -21.8% | +6.9% |
| Operating Income | $30.4M | -80.6% | +25.8% |
| Pre-tax Income | -$25.1M | -129.9% | +43.8% |
| Income Tax | -$5.0M | +76.5% | -160.3% |
| Net Income | -$20.2M | -119.2% | +61.8% |
| EPS (Basic) | -$0.11 | -119.3% | +65.6% |
| EPS (Diluted) | -$0.11 | -119.3% | +65.6% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $514.4M | +11.1% | — |
| Accounts Receivable | $242.3M | -63.7% | — |
| Inventory | $169.7M | +27.6% | — |
| Current Assets | $1.07B | -25.0% | — |
| Total Assets | $5.64B | -6.6% | — |
| Current Liabilities | $1.28B | -9.1% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $477.3M | — | — |
| Capital Expenditures | $61.0M | — | — |
| Investing Cash Flow | -$137.7M | — | — |
| Financing Cash Flow | -$215.7M | — | — |
| Free Cash Flow | $416.3M | — | — |
| Long-term Debt | $2.61B | -6.8% | — |
| Total Liabilities | $4.87B | -7.3% | — |
| Stockholders' Equity | $775.3M | -2.4% | +77.6% |